Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 10, 2021, Verrica Pharmaceuticals Inc. (the "Company") held its 2021 annual meeting of stockholders (the "Annual Meeting"). The stockholders considered two proposals, each of which is described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 23, 2021. Of the 27,514,720 shares outstanding as of the record date, 22,355,539 shares, or 81.24%, were present or represented by proxy at the Annual Meeting. Set forth below are the results of the matters submitted for a vote of stockholders at the Annual Meeting.

Proposal No. 1: Election of two nominees to serve as directors until the 2024 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows:





Name             Votes For        Votes Withheld
Ted White         16,561,904            1,663,777
Mark Prygocki     17,475,738              749,943

Broker Non-Votes: 4,129,858.

All nominees were elected.

Proposal No. 2: Ratification of the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2021. The votes were cast as follows:





                                                Votes For         Votes Against        Abstained
Ratification of appointment of KPMG LLP          22,155,940              199,410              189

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses